


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
+4.79%
-2.40%
-4.96%
-12.16%
-2.01%
CRDF
Cardiff Oncology Inc
$1.87
CRDF Price Performance
$1.6 (+16.88%)
$2.41 (-22.41%)
$2.21 (-15.38%)
$3.75 (-50.13%)
Overall standing based on market and analyst consensus.
Hover over the category for more information
Earnings
Earnings
Rating
Rating
Momentum
Momentum
Price value has negative momentum
Activity
Activity
Future
Future
CRDF Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
CRDF Street Sentiment is extremely bullish and have negative views on the near-term outlook
CRDF has Extreme risk level
Risk Indicators
Sentiments overview associated with events and the stock performance
Average key support and resistance price levels
What is CRDF current stock price?
What are CRDF stock strengths?
What is CRDF Risk Level?
What is CRDF market cap and volume?
What is CRDF current Stock IQ?
Should I buy CRDF stock right now?
Is CRDF a Strong Buy right now?
What does a 'Strong Buy' rating mean for CRDF?
What does a 'Strong Sell' rating mean for CRDF?
What factors influence CRDF's Stock IQ?
Join our subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
CRDF
Cardiff Oncology Inc
Current Price
$1.87

CRDF Price Performance
$1.6 (+16.88%)
$2.41 (-22.41%)
$2.21 (-15.38%)
$3.75 (-50.13%)
CRDF Analysts Opinion
Overall standing per market and analyst expectations.
Hover over the category for more information
Earnings
Earnings
Rating
Rating
Momentum
Momentum
Price value has negative momentum
Activity
Activity
Future
Future
CRDF Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
CRDF Street Sentiment is extremely bullish and have negative views on the near-term outlook
CRDF has Extreme risk level
Risk Indicators
Average key support and resistance price levels
CRDF Stock IQ
Stock Insights
Not Enough Information
CRDF Latest Analysis
CRDF: 10-K Filing Prompts Model Update . By John Vandermosten CFANASDAQ:CRDFREAD THE FULL CRDF RESEARCH REPORT2025 Financial ResultsCardiff (NASDAQ:CRDF) reported 2025 financial and operational results in a press release and Form 10-K filing with the SEC on February 24th 2026. Later that day CEO Dr. Mani Mohindru participated in Oppenheimers Healthcare Conference providing the companys latest status. For the twelve-month period ending December 31st 2025 revenues of $593000 were reported and ope
Mon Mar 2, 2026
Cardiff Oncology to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference.
Thu Feb 19, 2026
FIND US ON
Unlock the knowledge that 5,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
CRDF Stock trends
CRDF Stock performance
CRDF Stock analysis
CRDF investment strategies
Disclaimer:
The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained.
The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.